LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin - LiPlaCis®, Oxaliplatin - LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects. LiPlasomes most advanced program I LiPlaCis® in a close escalating clinical phase I trial. In addition two programs are in pre-clinical development.
View Top Employees from LiPlasome Pharma A/S| Website | http://www.liplasome.com |
| Revenue | $5.8 million |
| Employees | 13 (5 on RocketReach) |
| Founded | 2001 |
| Address | 378 Diplomvej, Kongens Lyngby, Capital Region 02800, DK |
| Phone | (458) 870-8020 |
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Drug Delivery, Manufacturing, Science and Engineering, Other Pharmaceuticals and Biotechnology, Pharmaceutical, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular LiPlasome Pharma A/S employee's phone or email?
LiPlasome Pharma A/S Questions
The LiPlasome Pharma A/S annual revenue was $5.8 million in 2024.
5 people are employed at LiPlasome Pharma A/S.
LiPlasome Pharma A/S is based in Kongens Lyngby, Capital Region.
The NAICS codes for LiPlasome Pharma A/S are [32541, 32, 3254, 325].
The SIC codes for LiPlasome Pharma A/S are [283, 28].
Top LiPlasome Pharma A/S Employees
-
35+
-
1
Related Companies
